ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

EGAN vs DH // DIVIDEND YIELD & FCF PAYOUT SAFETY

eGain Corporation (NASDAQ) VS. Definitive Healthcare Corp. (Class A) (NASDAQ) • 15-METRIC TALLY: EGAN 3 — DH 6
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (EGAN VS. DH) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC EGAN DH SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin 70.10% 75.90% -5.80 DH /gross-margins <GO>
Return on Invested Capital (ROIC) 46.70% -35.00% +81.70 EGAN /roic <GO>
EV/EBITDA & P/E Valuation 15.3x — — TIE /valuation <GO>
Free Cash Flow Yield 3.13% 22.82% -19.69 DH /fcf-yield <GO>
Operating Margin 5.00% -60.00% +65.00 EGAN /operating-margins <GO>
Net Profit Margin 36.50% -57.50% +94.00 EGAN /net-margins <GO>
Revenue Growth (YoY) -4.70% -4.20% -0.50 DH /revenue-growth <GO>
Dividend Yield & FCF Payout Safety ACTIVE 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity 0.20 0.20 0.00 TIE /balance-sheet <GO>
Piotroski F-Score Quality 6/9 7/9 -1.00 DH /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 57.0 63.9 -6.92 DH /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple 4.4x — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $150.1M $162.4M -$12.3M DH /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR EGAN REV DH REV EGAN GROSS % DH GROSS % EGAN FCF DH FCF
FY 2025 $88.4M $241.5M 70.1% 75.9% $4.7M $37.1M
FY 2024 $92.8M $252.2M 70.3% 78.3% $12.3M $45.9M
FY 2023 $98.0M $251.4M — — $4.6M $41.2M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
EGAN // BETA —
DH // BETA —